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ABSTRACT
As the genomics revolution continues, there is constant pressure to make sequencing
technology more accessible and practical for a growing series of applications. Existing
sequencing technologies are often prohibitively expensive, limiting their use for novel diagnostic
and research applications. Additionally, existing technologies are often limited by short read
lengths, which may present problems to certain quantitative sequencing applications. One such
application is Differential Expression Analysis, in which RNA-Seq is performed in paired
samples under different experimental conditions to identify differences in gene expression. In
this study, an Oxford Nanopore Technologies sequencing platform was used to conduct a
differential expression study to identify Notch targets. Notch is a transcription factor that
regulates numerous functions related to cellular growth and development, and misregulations in
the Notch pathway can lead to developmental disorders and cancer. Nanopore Sequencing offers
a cheaper and potentially more effective way to conduct research on Notch-mediated expression.
It was found that while nanopore sequencing offers a cheaper alternative to existing methods,
additional development of the technology is required to perform at the same level as current
research standard platforms in differential expression.
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1 Introduction
1.1 Modern sequencing technologies
1.1.1 Sequencing by Synthesis
The past few decades have seen a shift in how biology is studied. New, high-throughput
nucleic acid sequencing technologies are able to sequence entire genomes and transcriptomes for
routine scientific experiments. This has revolutionized cancer research [1][2], disease research,
and other basic science applications [3][4], such as the complete human genome project [5].
Refining and improving existing sequencing methods remains an active area of research.
Second generation high-throughput sequencing methods predominantly work via
sequencing by synthesis (SBS) mechanisms. In SBS, the nucleic acids to be sequenced are
fragmented. These fragments are replicated, and reads are obtained as new nucleotides are
integrated into the new fragments. In ion torrent sequencing [6], four nucleotides are cycled
through the sequencing chamber. If the current nucleotide is integrated into the growing nucleic
acid chain, it will produce hydrogen ions, producing a shift in the pH of the surrounding
environment. This shift is detected and recorded as the next nucleotide in the chain, and the free
nucleotides are flushed out to prepare for the introduction of the next nucleotide to be tested.
Similarly, Illumina sequencing uses chain-terminating, nucleotide analogs with an
attached fluorescent group known as a fluorophore. Sequencing reads are generated as
replication occurs. Polymerase replication of the template strand integrates these nucleotides into
the copy, which is then imaged. Each nucleotide is represented by a unique color, so this image
will represent the exact nucleotide integrated into the strand. After the image is taken, the
fluorophore is removed, and replication proceeds to sequence the next nucleotide. Both
technologies have become a research standard due to their high accuracy and throughput. The
high redundancy of information contributes to this accuracy. In both cases, sequencing data is
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taken on groups of identical strands that have been amplified immediately prior to sequencing.
Each group represents a small fragment of the original sample, but both technologies allow all of
these groups to be sequenced in parallel, dramatically increasing the throughput of these
sequencing platforms [7][8].
Some differences exist between the two platforms. Most notably, Illumina sequencing
allows for paired-end reads. By sequencing the complement of a fragment from the reverse end,
accuracy in Illumina sequencing is increased. Ion torrent generally has more inconsistent read
lengths than Illumina, whereas Illumina maintains a consistent read length. Practically, however,
these technologies perform similarly for quantitative applications [9].
Widespread adoption of these platforms has permitted the development of many
sequencing techniques, such as whole genome sequencing, metagenomic analysis, and
quantitative resequencing techniques such as differential expression (DE) analysis. In DE
analysis, RNA Sequencing (RNA-Seq) is performed on multiple experimental samples that
differ. In RNA-Seq, RNA is captured from a biological sample, converted to cDNA, and
sequenced. In differential expression, these may be a drug treated set of culture cells vs a control
set of cultured cells, a genetically distinct population of organisms vs a control population, or
any other situation in which the effects of a particular biological variable’s effect on gene
expression is being studied [9]. For every gene in the RNA-Seq dataset, genes that are expressed
at statistically significantly different levels can be identified. DE studies strongly benefit from
the high precision and throughput of SBS platforms. High throughput ensures that a significant
portion of the sample is sequenced, reducing experimental variation, and high accuracy ensures
that all of the sequenced reads can be accurately mapped to their corresponding transcripts for
quantitation [10].
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SBS, however, has several key drawbacks. SBS is dependent on DNA polymerases to
synthesize new strands as part of the sequencing process. Most polymerases, however, have a
limit in the length of new strand that is produced. When this limit is reached, the read cannot
continue, limiting the size of each fragment being sequenced. With modern technologies, this
limit is typically between 50bp and 300bp per fragment [11]. Most applications require
sequencing of fragments much larger than this. Human mRNA typically averages 3kb in length,
and genomic sequencing requires reads that cover large lengths of a chromosome. Several
analysis techniques have been developed to address these issues. In de novo sequencing, where
no reference sequence is available, overlaps between reads must be detected computationally.
These reads are then assembled into a complete sequence [12]. The process of sequence
assembly is computationally intensive, and often requires context specific changes to existing
methods to be as accurate as possible [13]. Even after optimization, assembly still introduces
potential error to sequencing experiments in particular situations, such as high error rate
experiments or repetitive regions [14][15]. In resequencing applications such as DE, assembly is
not necessary. Instead, reads that map to a particular reference are quantitated, but must then be
normalized to allow comparison between genes and reference regions of different lengths [10].
Both methods are imperfect, and improving the computational basis of assembly and read
quantitation is an area of active research. Additionally, the chemical environment and sensors
required to facilitate SBS require large, expensive instrumentation, which may be prohibitive to
use in fieldwork environments or any time that cost is prohibitive. Finally, since SBS does not
directly sequence the original strand, epigenetic modifications cannot be directly detected,
necessitating additional sample preparation steps [16].
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1.1.2 Nanopore Sequencing
To address these shortcomings, novel ultralong sequencing techniques have been
developed. PacBio sequencing has found numerous applications and offers long read length, but
still suffers from high instrument cost and low accuracy [17]. To address the issues of traditional
second-generation sequencing platforms, and provide an alternative to PacBio sequencing,
Oxford Nanopore Technologies (ONT) developed a nanopore sequencing platform.
In ONT sequencing, nucleic acid molecules are drawn through a protein nanopore
embedded in a membrane. An electric current is run across the membrane and through the pore.
As different individual nucleotides are drawn through the pore, the electrical resistance of the
pore changes dependent on the individual nucleotide currently in the pore, as well as surrounding
nucleotides and epigenetic modifications of the nucleotides [18]. To generate sequence data from
this electrical trace, machine learning algorithms such as guppy are used [19]. These algorithms
are trained on known sequences, and correlate noisy electrical signals to a series of nucleotides
[19].
ONT sequencing offers numerous benefits when compared to SBS. Most notably, there
are no theoretical limits to the length of a single nucleic acid read on a Nanopore platform, and
reads over 2MB in length have been recorded. In applications such as DE analysis, this allows
for full transcripts to be sequenced, alleviating the need for assembly and providing more direct
quantitation. Long reads also allow regions of the genome that were previously unsequenced to
be sequenced and assembled, such as repetitive regions in centromeres and telomeres [20].
ONT devices have their own set of drawbacks, however. ONT sequencing platforms offer
a 90% to 95% single nucleotide read accuracy, compared to Illumina’s 99.9% accuracy rate [21].
This problem can be alleviated in multiple ways. In resequencing applications, the length of the
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overall read provides enough matches to accurately map a sequence to reference sequences [22].
In de novo sequencing and single nucleotide polymorphism identification, additional, redundant
data must be used to form a consensus sequence [23]. This data may be supplied by additional
nanopore runs, or from targeted sequencing runs performed on SBS devices in a process known
as hybrid assembly [24].
The throughput of ONT devices is also limited by the lifespan and fuel availability of the
pores themselves. Translocation of nucleic acids through a pore is dependent on ATP provided by
added buffers, as well as the maintenance of the pore structure itself. As the sequencing run
continues, ATP is consumed and pores lose their stability. Adding more ATP during sequencing is
possible, however, limitations in the fluid capacity of the flow cell and structural changes in the
protein pores eventually result in pore inactivation. As such, the number of available pores for
sequencing decreases over time. As the number of pores decreases, the rate of data collection
does as well. When the number of available pores decreases to zero, no more data can be
collected from the sample. Pores can remain active for up to 72 hours, however, there is much
variation in pore lifespan, often resulting in sequencing runs ending before this [21].
ONT seeks to alleviate this problem by offering platforms with additional pores. Flongle
and MinION devices offer cheap upfront costs for low volumes of sequencing data, however,
their flow cells only contain 126 and 512 pore channels respectively[25]. The PromethION
sequencer offers 2975 pore channels per flow cell and can run up to 48 flow cells in parallel,
however, the device itself is much more expensive than other ONT sequencers (Table 1). The
total throughput of the Promethion, however, can reach a scale comparable to Illumina
sequencing. While variable, 50-150GB of total PromethION reads have been recorded from a
single flow cell when sufficient material is sequenced [26][18].
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Platform
SBS Platforms
Illumina MiSeq
Illumina HiSeq 2000
Ion Torrent PGM
ONT Devices
Flongle
MinION
PromethION
Other long-read devices
PacBio RS

Instrument
Cost

Cost per GB
(Approximate)

$128,000
$654,000
$80,000

$502
$40
$1000

Theoretical Maximum Number of
Available Pores per Flow Cell (ONT
Devices)
-

$2,500
$1,000
$10,000

$50-$1000
$50-$1000
$20-$40

126
2048 (512 channels)
12000 (2675 channels)

$695,000

$40-$80

-

Table 1. Cost comparison of sequencing platforms. Initial instrument cost may vary dependent on
manufacturer availability. Cost per GB varies dependent on technical variation of the experiment
and total data to be collected per sample. In particular, Flongle and MinION sequencing cost is
highly dependent on total data acquisition, which in turn is dependent on technical factors such as
reagent quality and library concentration [27][28].

1.2 Application of Nanopore Sequencing to Differential Expression
1.2.1 Adapting SBS Computational Tools to Nanopore Sequencing
As discussed previously, differential expression studies are well established on SBS
platforms, however, they remain an emerging technology on newer platforms such as nanopore
sequencing. In theory, ONT sequencers offer full transcript coverage and direct RNA sequencing,
both of which reduce the complexity of analysis in DE studies. Current differential expression
methodologies for ONT devices closely parallel those used for SBS platforms [29][30][31]. The
differences between the traditional SBS reads and ONT reads, however, mean that some key
factors must be considered.
One such factor is mapping quality of nanopore reads to a reference genome or
transcriptome. Current ONT settings for minimap2 consider both the long-read length and low
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single nucleotide accuracy of nanopore reads [29]. Single nucleotide mismatches between the
read and a reference are penalized less, however, longer reads mean that more consensus of the
overall sequence is required to match a read to a reference. The accuracy that long read mapping
can provide despite low single nucleotide accuracy extends the utility of nanopore sequencing in
resequencing applications such as differential expression [32].
Aside from scoring during alignment, long reads present additional challenges for
mapping software. Current read quantitation software, such as RsubRead, expects an alignment
file generated using a reference genome as opposed to a transcriptome. Genes are then
quantitated based on alignment position using a separate gene annotation file. This allows certain
information, such as chromosomal location of mapped genes, to be preserved [32]. Currently,
recommended DE pipelines for ONT devices use a genomic reference set for alignment, as a
genomic alignment paired with an annotation file describing gene locations should also properly
match genes. These pipelines use Salmon to quantify based on Transcripts per Million (TPM), a
normalization method used to account for short read data that does not cover a whole transcript
[29]. Some studies have instead used transcriptomic reference data during mapping for nanopore
sequencing of RNA in eukaryotes [31]. Longer nanopore reads are more likely to span multiple
introns, and also more completely represent a splice variant, indicating that genomic mapping
techniques used in SBS may not be entirely applicable [31][33]. This disagreement indicates that
refining mapping strategies in nanopore sequencing pipelines remains an open area of research.

1.2.2 Application to Notch Signaling
The Notch family of transcription factors is responsible for regulating expression of a
variety of genes involved in cellular growth and development. As such, misregulations in Notch

- 14 -

Comparison of an Oxford Nanopore Technologies Sequencing Platform to Existing Sequencing Methods for Differential Expression Studies

signaling are implicated in a variety of developmental disorders and cancers, making it a critical
active area of research [34].
Normally, Notch is a transmembrane protein. When it binds to an extracellular ligand,
however, the gamma-secretase enzyme complex cleaves the intracellular domain from the rest of
the protein. From here, Notch translocates to the nucleus, where it forms a complex with other
transcription factors such as MAML1 (Mastermind-like 1) and CSL (CBF1, suppressor of
hairless, Lag-1). This complex drives transcription of downstream genes by binding to their
promoters or enhancers at a consensus sequence known as a Notch Response Element (NRE).
NREs may appear individually, or may also have a second, reverse complement NRE 12-17
nucleotides downstream of first NRE. This head-head configuration is known as a Sequence
paired Site (SPS), which recruits a similarly dimeric form of the Notch Transcriptional complex
[35].
This pathway is well characterized in canonical Notch targets such as Hes family genes,
however, there are still many questions in Notch research. Notably, the exact role of dimeric
Notch binding in driving transcription remains unclear. Impaired Notch dimerization is
associated with a loss of expression in downstream Notch targets, suggesting that dimeric Notch
in either the enhancer or the promoter of a Notch target gene is required for robust activation of
transcription. These results, however, are largely based on canonical Notch targets, such as HES1
and HES5, and gaining a whole genome perspective on Notch-mediated gene expression remains
an active area of research [36].
Since it is a newer technology than other sequencing platforms, nanopore sequencing has
yet to be used for various applications that have already been studied on an Illumina platform.
The benefits of an ONT platform discussed above mean that new insights may be gained from
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applying nanopore sequencing to these scientific questions. Comparisons between platforms are
necessary to determine the effectiveness of nanopore sequencing towards these scientific
questions, however. In this study, we used an ONT MinION to identify Notch target genes with a
differential expression workflow. These data were compared to data produced using an Illumina
platform to assess the effectiveness of nanopore sequencing in this context.
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2 Methods
2.1 cDNA library preparation from cultured T-ALL cells
Library preparation is summarized in Figure 1, with detailed methodology following.
2.1.1 Cell Culture, Treatment, and double-stranded complementary DNA (dscDNA) preparation
SUPT1 T-cell acute lymphoblastic leukemia (T-ALL) cells were used due to the
constitutively active Notch signaling in T-ALL cell lines [37]. Cells were grown in Roswell Park
Memorial Institute (RPMI) media supplied from Sigma-Aldrich with 10% Fetal Bovine Serum
(FBS) and 1% antibiotic/antimycotic solution in a 37ºC incubator with a 5% CO 2 atmosphere.
To study Notch signaling, the Gamma-secretase inhibitor DAPT was used to prevent NOTCH1
cleavage at the cell membrane, preventing downstream Notch-mediated transcription [38]. Genes
found to be downregulated by DAPT during analysis are therefore identified as Notch targets.
Experimental SUPT1 cells were treated with 5µM of DAPT for 24 hours. Control SUPT1 cells
were treated with 5µM of DMSO for 24 hours. 10 6 cells were treated per sample. Total RNA
extraction was performed using the recommended protocol for the Invitrogen TRIzol Reagent
(Cat# 15596026). Five paired treatments of DAPT and DMSO were performed.
Double-stranded blunt-end cDNA was generated from extracted mRNA using Thermo
Scientific Maxima H Minus Double-Stranded cDNA Synthesis Kit (Cat# K2561). Poly-A Plus
mRNA was purified from 1 microgram of total RNA. dscDNA generation followed the
recommended manufacturer’s protocols for synthesis using oligo-dt primers with the purified
polyA+ mRNA. Purified polyA+ mRNA was not quantitated.

- 17 -

Comparison of an Oxford Nanopore Technologies Sequencing Platform to Existing Sequencing Methods for Differential Expression Studies

Figure 1. Wet lab workflow was consistent across 5 paired trials. SUPT1 T-ALL cells were
treated with the Gamma Secretase Inhibitor DAPT to inhibit Notch mediated transcription.
Genes that lost expression when compared to a DMSO control represent Notch target genes.
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2.1.2 Oxford Nanopore Technologies Sequencing Library preparation
Blunt end double stranded cDNA is functionally similar to blunt end gDNA fragments,
and as such, gDNA library preparation protocols may be used. Sequencing library preparation
was performed using the ONT Ligation Sequencing Kit (Cat# SQK-LSK110). Additionally,
samples were barcoded using the ONT PCR Barcoding Expansion 1-12 (Cat#EXP-PBC001). In
barcoding, each sample is ligated with a unique sequence. This sequence is then used to PCR
amplify each sample. Multiple samples can then be pooled together into a single library and
demultiplexed during analysis using the known barcode sequences. Library preparation was
performed according to recommended ONT protocols for the Ligation Sequencing Kit with the
added PCR Barcoding Expansion[39].
Samples were loaded onto an ONT R9.4.1 MinION flow cell (FLO-MIN106D) for
sequencing on a MinION device. Assuming an average mRNA length of 3.4kb [36], 40 fmol of
each sample was loaded onto a flow cell. cDNA libraries were quantified immediately prior to
sequencing using the Promega QuantiFlour dsDNA System (Cat# E2671). Data was collected
until the active pore count reached 0. 200µL of ATP containing ONT Flush Buffer (Cat#EXPFLP002) was added to each flow cell 12 to 13 hours prior to the start of each sequencing run to
extend active pore lifespan. Paired samples E1, E3, and E4 were sequenced simultaneously on
the same flow cell. Samples E5 and E6 were sequenced together on a separate flow cell from the
other three paired trials due to limitations in total load capacity of MinION flow cells.

2.2 Differential Expression Analysis of RNA-Seq data
Computational pipelines used are summarized in Figure 2, with detailed methodology following.

- 19 -

Comparison of an Oxford Nanopore Technologies Sequencing Platform to Existing Sequencing Methods for Differential Expression Studies

A.

B.

C.

Figure 2. Comparison of different differential expression analysis pipelines for ONT data. 2A.
DE expression analysis pipeline provided by ONT [29]. RNA-Seq reads are mapped to the
human reference genome using Minimap2 ultralong read settings. 2B. Final analysis pipeline.
Reads are mapped to the human reference transcriptome, and then normalized on a per-sample
basis using DESeq2’s median of ratios normalization method. 2C. Illumina Analysis pipeline.
Data was accessed in .fastq format from Gene Expression Omnibus, and preprocessed using
Fastp.
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2.2.1 Computational Resources
Differential Expression analysis involves several computationally intensive steps. Most
notably, mapping reads to a reference and quantitating mapped reads require large computational
resources. The San José State University College of Science High Performance Cluster was used
for mapping and quantitation steps. Basecalling and demultiplexing was performed using parallel
CUDA processing with an NVIDA gtx 1660 ti.

2.2.2 Basecalling and Demultiplexing
The default output file of the ONT MinION is .fast5, an electrical trace file. To obtain
sequencing reads, this electrical trace must be basecalled to translate electrical resistances to
nucleotides. Additionally, barcodes must be identified within the pooled library to determine
which sample each individual read originated from. Both of these steps were performed using the
ONT Guppy basecaller [19]. ONT provides multiple preconfigured settings depending on library
preparation kits and flow cell combinations. Settings were used for configuration
dna_r9.4.1_450bps_hac, which is used for the LSK110 sequencing kit and PBC001 expansion.
Reads were output in .fastq format [40].

2.2.3 Removal of Adapter and Barcode sequences using Porechop
During sequencing library preparation, two additional sequences are ligated to each read:
a barcode to identify the original sample, and an adapter sequence that allows the read to bind to
the nanopores themselves. Both of these sequences, however, are not part of the mRNA sequence
itself, and are extraneous after demultiplexing has occurred. Additionally, reads are sometimes
ligated to adapters in a read-adapter-read configuration, causing errors in quantitation. The
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Porechop adapter trimmer was used to remove these nucleotides from the mRNA reads and split
misligated reads from each other [41]. chopLoop.sh was written to run Porechop settings
reproducibly, and is available at https://github.com/nklier38/ONT_MinION_Notch_DE [42].

2.2.4 Reference Genome and Transcriptome
cDNA reads were mapped to the Genome Reference Consortium Human Build 38 patch
release 14 (GRCh38.p14) or the associated transcriptome in fasta format [43], obtained from
UCSC genome browser ftp server. Initially, reads were aligned to the reference genome (Figure
2A), based on the recommended pipeline from ONT [29]. Custom developed pipelines for this
project used the reference transcriptome (Figure 2B, 2C) due to concerns with gene discovery
(Figure 4). All samples were run through both pipelines 2A and 2B for comparison. Since the
SUPT1 cell line is not sequenced, alignment to the human reference genome is an accepted
protocol for aligning sequencing reads [44].

2.2.5 Mapping Reads to Reference Sequences
cDNA reads were mapped to reference source using splice-aware ONT ultralong read
settings for minimap2 (version 2.24) [44]. Reads were outputted in the .sam alignment file
format. mapLoop.sh and mapLoopGenomic.sh were written to run the described settings
reproducibly. Both are available at https://github.com/nklier38/ ONT_MinION_Notch_DE
[42].For mapping to a reference transcriptome, standard long read ONT settings were used (-ax
map-ont). For a genomic record, splice-aware settings were used (-ax splice). Data access
instructions are available at https://github.com/nklier38/ONT_MinION_Notch_DE [42].
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2.2.6 Quantitation of Transcripts Found for Each Gene
The number of reads aligned to each gene in the reference transcriptome were counted
using the python script readCounter.py. The function of the python script is identical to the
featureCounts function of RsubRead [32], however, RsubRead requires .sam files that have been
aligned to a reference genome as opposed to the transcriptome used in Figure 2B and 2C. An
additional gene annotation file is then required to show the locations of Transcription Start Sites,
Exons, Introns, and Transcription Termination sites. This information is used to correlate
sequencing data to known genes, allowing expression levels of these genes to be quantified.
readCounter.py uses a more direct approach. In a reference transcriptome, each unique transcript
is denoted by its accession number. This information is assigned to each read in the mapping file.
The number of reads assigned to each accession number can then be counted by looping through
each .sam file and counting how many times each transcript has reads mapped to it.
readCounter.py is available at https://github.com/nklier38/ONT_MinION_Notch_DE [42].
To test that readCounter.py functioned similarly to RsubRead in this use case, an artificial
annotation file was generated with entries for the five target genes in Table 2. The annotation file
used for genomic data contains chromosome names to identify location. These were replaced
with annotation numbers for the representative genes.

2.2.7 Statistical Analysis using EdgeR
Quantified reads were analyzed to calculate fold changes and significance between the
DAPT and DMSO control groups. The EdgeR statistical analysis package was used in the
pipeline shown in Figure 2A in accordance with ONT recommendations [29][45]. Fold-changes
are calculated as the log base 2 of the change from the DMSO control to the experimental group.
All p-values used are calculated assuming a negative binomial distribution. These are then
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adjusted using the Benjamini-Hochberg (BH) post-hoc adjustment with an FDR cutoff of 0.05.
The script edgerRunner.R was written to run edgeR analysis using these settings, and is available
at https://github.com/nklier38/ONT_MinION_Notch_DE [42].

Quantitation Method
readCounter.py

RSubRead

Experiment
e1 DMSO
e1 DAPT
e3 DMSO
e3 DAPT
e4 DMSO
e4 DAPT
e1 DMSO
e1 DAPT
e3 DMSO
e3 DAPT
e4 DMSO
e4 DAPT

HES4
416
17
110
31
87
6
416
17
110
31
87
6

HES5
0
0
0
0
0
0
0
0
0
0
0
0

Gene Name
HES1
HEY1
132
266
6
24
34
120
7
3
15
149
4
23
132
266
6
24
34
120
7
3
15
149
4
23

GAPDH
6199
1907
2649
1431
1747
3032
6199
1907
2649
1431
1747
3032

Table 2. Comparison of Quantitation methods using methods described. Discovered counts
were found to be consistent between readCounter.py and the RsubRead featureCounts
function.
2.2.8 Normalization and Statistical Analysis using DESeq2
To account for variation between samples, DESeq2 median of ratios normalization was
performed [46]. Median of ratios is an internal normalization performed independently on each
sample to account for the individual variation between samples. While edgeR is capable of
performing trimmed mean of M-value normalization, median of ratios normalization was
selected based on its previous usage in similar differential expression studies [40]. In the
computational pipelines shown in figure 2B, DESeq2 was used to perform a Wald test assuming
a negative binomial distribution. BH adjustment was then performed with a p-value cutoff of
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0.05. The script DESeqRun.R was written to run DESeq2 with these settings, and is available at
https://github.com/nklier38/ONT_MinION_Notch_DE [42].

2.2.9 Procurement and Preprocessing of Illumina Data from CUTLL Ce1ls
The normalized DE analysis pipeline (Figure 2C) was also performed for a similar
experiment performed on an Illumina platform. Data was obtained using a similar wet lab
protocol to Figure 1, however, CUTLL cells were used, and sequencing was performed on an
Illumina HiSeq 2000 [36]. The computational pipeline for Illumina analysis used the same
software and paralleled the Nanopore pipeline when possible, with settings adjustments to
account for short Illumina reads (Figure 2C). Data was sourced from NCBI Gene Expression
Omnibus series GSE 72482. Measures of run performance, such as lane usage, were not
provided. FastP was used for end trimming and quality control of Illumina data, using default
single-end settings with no alteration [47]. CUTLL and SUPT1 cells are both T-ALL cell lines
noted for their Notch activity and upregulation of key targets [48]. As such, this cell line was
considered acceptable for comparison purposes; however, some variation in gene expression may
be explained by these differing cell lines.
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3 Results
3.1 Performance of a Nanopore Platform in Differential Expression Analysis
3.1.1 Read Length Performance
One of the primary advantages of nanopore sequencing is the potential to produce
ultralong reads. The average length of mature human mRNA is 3.4 kb [36]. It is therefore well
within the capabilities of nanopore sequencing to consistently sequence whole transcripts;
however, this is not the case in these experiments. The modal fragment sequenced was 500-600
bp in length, and few fragments reached the expected size for mRNA (Figure 3A).
Read lengths were also represented as fractions of the size of the gene they mapped to
(Figure 3B), calculated as the length of a read divided by the length of the gene that read mapped
to. A value below 1.0 indicates a read smaller than the length of the gene it represents, whereas a
value above 1.0 indicates a larger read than the gene. A small number of values above 1.0 are
expected due to ligation products and alternative splicing, which is shown in the histogram.
Porechop allows for ligation products in a read-adapter-read configuration to be properly split,
however, ligation products that constitute reads directly ligated to other reads are outside of
porechop’s capabilities [41]. After Porechop processing, an average of 91.2% of read data was
retained. The histogram peak indicates that many reads did in fact represent their whole target
gene, however, a modal number of reads only exhibited 30%-50% coverage of a gene.
To examine whether reduced gene coverage was correlated with longer genes, gene
length was plotted vs proportional gene coverage (Figure 3C). Each read in the scatter plot is
represented as a single point. Due to the large number of reads in the dataset, this was further
condensed into a heatmap of scatterplot points. Linear regression analysis shows a distinct
negative correlation between gene length and coverage of that gene.
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A.

B.

C.

Figure 3. Assessment of read lengths of Nanopore reads. 3A. Histogram of lengths of mapped
reads. The most reads were found to be less than 1kb in length. 3B. Histogram of read lengths
represented as a fraction of the length of the gene they were mapped to. A value of 1.0
indicates full coverage of the gene. The peak at 1.0 indicates that full coverage did occur in
some genes, however, most genes were represented by reads less than half their length. 3C.
Smoothened scatterplot of the proportion described in 3B correlated to overall gene length.
Scatterplot points are binned in square areas on the graph. More intense blue coloration
represents more points in that bin. A weak but distinct negative correlation is observed, and a
large number of fully mapped genes are seen as being less than 2000bp in length.
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The negative correlation is weak, but highly significant(R 2 = 0.04124, p = 2.2 *10-16), indicating
a significantly negative but non-linear trend. Genes that are fully represented by their reads are
more frequently shorter, as is shown by the heatmap intensity of shorter genes at 1.0 coverage
(Figure 3C).

3.1.2 Total Acquired Nanopore Sequencing Reads Compared to MinION Flow Cell Loading
Capacity
As discussed in 1.1.2, a MinION flow cell is limited by the lifespan of its sequencing
pores [21]. Once all pores are inactive, no more sequencing data can be acquired. This is often
well before all possible reads have been sequenced. Additionally, suboptimal ligation efficiency
during library prep may result in some cDNA molecular being unreadable. To demonstrate the
effects that these factors have on the data, the total mapped cDNA reads are shown for each
sample, alongside the total unmapped reads and the total number of reads that were theoretically
loaded onto the flow cell (Table 3). In all trials, the total number of acquired reads accounted for
less than 0.01% of the total loaded DNA molecules actually producing a mapped read. While
unmapped reads account for some of the loss in total data acquired, this accounts for far less than
reads that were never initially acquired during the sequencing run.
Mapped Illumina reads generally made up a higher proportion of theoretical reads,
compared to Nanopore reads, which made up small proportion of their theoretical library load.
This is partially because total loaded library was not provided, and the total theoretical number of
reads was computed based off of available data [36].
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Mapped Tran- Unmapped
Sample
scripts
Reads
E1-DMSO
1,400,381
309,949
E1-DAPT
982,026
229,125
E3-DMSO
802,217
242,784
E3-DAPT
424,115
126,346
E4-DMSO
650,376
74,299
E4-DAPT
1,172,960
136,909
E5-DMSO
88,071
21,434
E5-DAPT
88,105
14,688
E6-DMSO
29,665
4,882
E6-DAPT
90,333
23,087
Illumina ExUnmapped
periments Mapped Reads
Reads
DMSO 1
33,337,673
11,269,514
DMSO 2
39,269,378
9,762,649
GSI 1
42,561,984
18,687,267
GSI 2
34,622,606
13,089,058

Theoretical Transcripts
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
2.4*1010
Total Reads

Percent of Theoretical
Transcripts Mapped
0.005835
0.004092
0.003343
0.001767
0.00271
0.004887
0.000367
0.000367
0.000124
0.005835

44,607,187
49,032,027
61,249,251
47,711,664

Table 3. Total number of transcripts read and mapped compared to unmapped reads and total number
of loaded mRNA molecules. The theoretical number of transcripts in the sample represents the 40
loaded femtomoles of mRNA. Mapped reads exceeded unmapped reads, however, a low percentage
of collected reads from the original sample indicates low throughput. Data is also provided from
Illumina experiments [36]. Molar quantity of the library loaded was not given.

3.2 Comparison of Differential Expression Analysis Pipelines
3.2.1 Comparison of Transcriptomic and Genomic Alignments
To determine the most effective method of performing DE analysis, the two analysis
pipelines shown in Figure 2 were compared. It was found that mapping nanopore reads to a
genomic record caused notable problems during downstream analysis. Quantitation of many
target genes varied depending on whether a genomic or transcriptomic record was used (Table 4).
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Most notably, the well characterized Notch target Hes5 was found to be completely absent when
quantifying alignments that had been mapped to a genomic record, disagreeing with previous
data on the SUPT1 cell line [49][48]. Reads aligning to the HES5 record were recovered when
aligning to a reference transcriptome in DMSO control cells, but not in DAPT treated cells,
further matching known data about the cell line. A transcriptomic reference was therefore used
for future analysis pipelines. Transcriptomic alignment additionally changed the number of
identified reads in other genes compared to genomic alignments. Another key Notch target,
HEY1, saw a reduced number of identified transcripts, whereas other targets such as HES1
remained mostly unchanged when compared to genomic alignments (Table 4).

Identified Transcripts per Gene

Experiment
DMSO
Controls
E1-DMSO

Mapping reference type
HES5
Genomic 0

HEY1
266

HES1
132

84

133

120

34

38

33

149

15

Transcriptomic 12

46

14

Genomic 0
Transcriptomic 0

24

6

8

5

E3-DAPT

Genomic 0
Transcriptomic 2

3

7

0

6

E4-DAPT

Genomic 0
Transcriptomic 0

23

4

5

4

Transcriptomic 17
E3-DMSO

Genomic 0
Transcriptomic 12

E4-DMSO
DAPT
Treatment
E1-DAPT

Genomic 0

Table 4. Total number of transcripts mapped to representative genes using a genomic
reference (Figure 2A) compared to a transcriptomic reference (Figure 2B) for three
representative genes. In HES5, no transcripts are found when mapping to the genome, but are
present when mapping to the transcriptome. Less HEY1 transcripts mapped to the
transcriptome than to the genome, whereas results for HES1 remained largely unchanged.
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3.2.2 Effects of Normalization on Gene Quantitation
To evaluate technical variation between samples, the total number of successfully mapped
transcripts found in each sample was calculated (Table 5). Each number represents the total
number of transcripts that were successfully mapped to a gene. These counts should be
approximately equal, as sequencing libraries were loaded in equal quantities. Despite this, there
is notable technical variation between samples. This effect was most pronounced between
different flow cells. Paired trials E5 and E6 both exhibited lower total transcript counts than any
trial on the first flow cell.
DMSO Experiments
Total Number of
Mapped Transcripts

E1-DMSO
1,400,381

E3-DMSO
802,217

E4-DMSO
650,376

E5-DMSO
88,071

E6-DMSO
29,665

DAPT Experiments
Total Number of
Mapped Transcripts

E1-DAPT
982,026

E3-DAPT
424,115

E4-DAPT
1,172,960

E5-DAPT
88,105

E6-DAPT
90,333

Table 5. Total number of mapped transcripts found in each experimental sample. Variability in
total number of mapped reads provided initial justification for using normalized counts for
downstream statistical analysis.
Because of the variation in read counts between the different flow cells was seen between
each sample, DESeq2 median of ratios normalization was performed. Normalization of read
counts dramatically increased the number of significantly differentially expressed genes
identified. Only 19 genes were found to be differentially expressed upon DAPT treatment when a
genomic mapping pipeline was used. Mapping to a transcriptomic record and normalization increased the number of identified genes to 69 (Table 6). Total gene discovery was also assessed
for both platforms. Of the 11,265 unique transcripts identified on the Nanopore platform, 9976
were also found on the Illumina platform. The remaining 11.4% of unique transcripts on the
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Nanopore platform may be the result of differences between the CUTLL and SUPT1 cell lines;
however, this high overlap indicates that the two largely share patterns in gene expression.
Platform Total Upregulated
Genes with
post-hoc adjustment
Illumina- analyN.D.
sis from data
source[36]
Illumina
572
Nanopore- nor13
malized data
Nanopore- pre3
normalization

Total Downregulated Genes
with post-hoc
adjustment

Significant
genes per GB

Total
Unique
Transcripts

Total
throughput
(GB)

388

N.D.

N.D.

N.D.

1295
56

184.12
9.994

46,556
11,265

10.140
6.903

16

2.752

11,265

6.903

Table 6. Comparison of expression analysis to similar experiments performed in CUTLL cells
on an Illumina platform. To account for the increased total throughput of the Illumina
platform, total significant gene identification was divided by the total data output between all
trials to normalize for total throughput. For both measurements, Illumina outperformed
Nanopore sequencing in this differential expression application. Additionally, normalized vs
raw data was analyzed for target gene discovery. Normalization dramatically aided
differentially expressed gene discovery on a nanopore platform. Total unique transcripts,
whether significant or not, is also provided, as well as total throughput. In both measures,
Illumina outperformed Nanopore. The number of identified Notch targets presented by the
authors in the source paper of the Illumina data is also included in the top row [36]. While the
source paper provided all raw data, genes presented as Notch targets also had to meet
additional experimental criteria. The total number of upregulated genes was not provided. In
contrast, our analysis of the same data in the second row yielded more potential Notch target
genes, as it was based on differential expression analysis alone.
3.3 Identification of Notch Target Genes using a Nanopore Platform
3.3.1 Comparison of Nanopore Sequencing with an Illumina Sequencing Platform in Identifying
Notch Target Genes
The total number of significantly differentially expressed genes found on the ONT
Minion was 69, 56 of which were downregulated during GSI treatment and 13 upregulated
during GSI treatment. This set is dwarfed in comparison to the set of genes found on an Illumina
platform, which identified 572 upregulated genes and 1295 downregulated genes (Table 6). In
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both cases, significance was determined using Benjamini-Hochberg (BH) adjusted p-values. All
genes identified as significant in the nanopore sequencing data were also found to be significant
on the Illumina platform, suggesting that Illumina devices may be more applicable to DE
analysis. As shown in the last column of Table 5, this is partially because Illumina platforms
produce more data. Even when normalized for total throughput, however, nanopore sequencing
only yields about 8% of the number of significant genes as an Illumina platform. Extending
beyond significantly differentially expressed genes, the nanopore platform identified fewer
unique transcripts overall as well.
The source paper for Illumina RNA-Seq data provides different experimental criteria to
identify Notch target genes [36]. 388 Notch target genes were identified in total based on two
criteria: genes that were able to have expression rescued post-GSI washout, and genes identified
as Notch targets through Chromatin Immunoprecipitation sequencing. Due to these more
stringent conditions to identify a Notch target, the 388 genes presented in the source paper is
smaller than the 1295 downregulated genes identified using the analysis in Figure 2C.

3.3.2 Volcano Plot Representation of Nanopore and Illumina Data
For every gene found in the set of sequencing data, log-fold change in expression from
DMSO to DAPT was plotted versus the adjusted p-value of the difference in means between the
two groups (Figure 4A, 4B). Points further up and to the left indicate more significant and more
extreme downregulation of that gene. Points further up and to the right indicate more extreme
and significant upregulation. Key Notch targets are labeled, as well as the most significant and
most extreme up and down regulated genes in the nanopore data (Figure 4A) and Illumina data
(Figure 4B).
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B.

-log(p-adj)

-log(p-adj)

A.

Log-fold change

Log-fold change
Figure 4. Volcano Plots of differential expression on both an ONT and Illumina platform. 4A.
Volcano plot of GSI differential expression data collected in SUPT1 cells with an ONT MinION.
Log-fold change is calculated as fold change from control to GSI inhibition trials. Blue points
represented genes that are downregulated upon Notch inhibition. Labeled blue genes indicate
known Notch targets that exhibited downregulation. Red points indicate upregulated genes.
Labeled genes are the most extremely upregulated gene (NLRX1) and the most significantly
upregulated gene (DNTT). Grey genes were not significantly differentially expressed between
samples. Labeled grey genes represent housekeeping genes that are not expected to be
differentially expressed between trials. 4B. Volcano plot of GSI differential expression data
collected in CUTLL cells with an Illumina HiSeq2000. The same genes as the Nanopore Volcano
plot are labeled.

3.3.3 Significance, Fold Change, and Transcript Counts for Representative Genes
Log2 fold-change and p-value was calculated between the DMSO controls and DAPT
experimental groups (Table 7). Genes identified as downregulated upon DAPT treatment can be
considered Notch targets. HES1, HES4, HES5 are canonical Notch targets that were correctly
identified as being downregulated upon GSI treatment.
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Transcript Counts per Experiment
p-adj

E1

DMSO Trials
E3
E4
E5

55

30

47

49

8

207

-1.985

7.60E05
3.45E4
7.05E4
2.18E3
2.78E3
0.0182

-1.862

Houselog2
keeping
fold
genes change
GAPDH -0.0971

Downregulated
Genes
HEY1

log2
fold
change
-3.699

BMP4

-4.457

CPA4

-2.249

CR2

-2.882

HES1

-2.998

HES4
HES5

DAPT Trials
E3
E4
E5

E6

E1

E6

2

0

5

0

4

0

0

5

2

0

0

0

1

0

0

186

49

6

0

28

10

19

4

1

121

14

48

1

0

13

2

3

0

0

140

33

12

0

0

3

6

3

0

0

209

54

44

1

1

8

17

2

0

5

0.0280

225

66

48

1

0

0

2

0

2

5

p-adj

E1

E3

E4

E5

E6

E1

E3

E4

E5

E6

1

586

361

160

91

23

133

239

268

83

82

55

23

777

344

86

48

26
6

16
0

1032
5

426
6

285
7
488
3

46
8

40
6

PGK1

-0.0165

1

1887

615

ACTB

0.0065
9

1

1355
7

1041
6

141
9
292
9

Upregulated genes

p-adj

E1

E3

E4

E5

E6

E1

E3

E4

E5

E6

DNTT

log2
fold
change
1.516

75

22

51

2

1

119

38

202

7

20

FYB1

1.219

7.93E3
0.0418

42

21

24

6

0

95

19

128

3

8

NLRX1

3.533

0.0152

0

0

0

0

0

2

5

1

2

1

Table 7. Data table of differential expression in target genes. Log2 fold change represents fold
change in the number of identified transcripts from the DMSO control to DAPT treated
samples. Negative values indicate a decrease in expression, and represent identified Notch
targets. P-value was calculated between the DMSO control and DAPT groups using a
binomial exact test and Benjamini-Hochberg adjustment. Prior to calculation of fold change
and significance, transcript counts were normalized using DESeq2 median of ratios
normalization. Displayed transcript counts represent actual, non-normalized transcript counts
identified in each sample.
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HEY1 was found to have the most significant downregulation, followed by CPA4. BMP4
exhibited the most extreme downregulation, followed by HEY1, HES1, and CR2. Canonical
housekeeping genes (HKG) GAPDH, PGK1, and ACTB were chosen based on their standard as
RNA-Seq HKGs [50]. No significant difference was identified in these genes between
experimental groups. DNTT was found to have the most significant increase in expression, while
NLRX1 had the largest increase
in expression upon DAPT treatment.
3.3.4 Effects of Post-Hoc Adjustment on Notch Target Gene Discovery
Benjamini-Hochberg (BH) adjustment was used to investigate potential loss of Notch
target identification due to the high stringency provided by this post-hoc test. 255 total
significantly differentially expressed genes were identified before BH adjustment. Of these, only
135 were found to be significantly differentially expressed in the Illumina dataset before BH
adjustment. Two of these genes, PCGF5 and APP, were not represented in the Illumina dataset at
all, significant or not. In contrast, the 69 genes identified using Benjamini-Hochberg (BH)
adjustment on Nanopore DE data were all found to be significant within the Illumina set (Table
8).

raw p-value hits

post-hoc hits

Percent retained after
post-hoc adjustment

Illumina

255

69

27.059%

Nanopore

6625

1866

28.166%

Table 8. Effects of BH FDR adjustment and comparison to Illumina. Retention of significant
hits when a post-hoc test was applied was similar between platforms.
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3.3.5 Comparison to previous Nanopore RNA-Seq studies
To investigate whether our nanopore results were similar in throughput to previous
studies, RNA-Seq analysis was examined from Massui et al. (2021)[51]. This study is not a
differential expression study, however, broad statistics about total throughput are provided for
comparison. The question of whether nanopore results were comparable to Illumina data was
assessed by the authors by total gene discovery and agreement of discovered genes between
platforms. This study found results that largely agreed with Illumina data, however, they
collected 23 GB of total reads to achieve this goal (Table 9).

Total read data

Number of MinION Flow Cells
used

Total Nucleic
Acid load

Comparable
results to Illumina?

SUPT1 Notch DE

6.9 Gigabase

2 400 fmol

No

Cardiac Fibroblast
raw RNA-Seq[51]

23 Gigabase

5 1,000 fmol

Yes

Table 9. Comparison of throughput statistics from Massui et al. (bottom) to collected SUPT1
differential expression data (Top). While we did not achieve Illumina level results, data from
cardiac fibroblasts suggests that more samples, spread across more flow cells, collected
more data, may be necessary to achieve this.
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4 Discussion
4.1 Optimizing Existing Computational Resources for Long Nanopore Reads
Differential Expression Analysis remains an application that is not deeply explored on
Oxford Nanopore technologies platforms. The existing recommended pipeline is largely based
upon applications designed for short, high-accuracy Illumina reads. Most notably, the pipeline
fails to address the nature of long read data in two key ways.
Existing DE analysis pipelines map collected cDNA reads to genomic DNA. An
additional gene annotation file is then required to show the locations of Transcription Start Sites,
Exons, Introns, and Transcription Termination sites. This information is used to correlate
sequencing data to known genes, allowing expression levels of these genes to be quantified.
Genomic mapping is standard practice in RNA-Seq analysis [23][29][33]. RNA-Seq data is
sometimes mapped to a reference transcriptome instead [52][53]. The reference is composed of
known transcripts instead of a complete genomic record. Functionally, the major difference
between mapping a read to a genome and mapping to a transcript is that the genome includes
introns, whereas a transcriptome will include different splice variations. Separate annotation files
are used to add splice variant and intron position information to genomic references. Modern
mapping tools, such as Minimap2, can be run in a splice-aware fashion that ensures mapping can
occur between an RNA read and a genomic reference [44]. Due to the information found in the
annotation file, if a transcript is found in a reference transcriptome, there should therefore be no
difference between genomic mapping and transcriptomic mapping. If the transcript is not in the
reference transcriptome, however, then it will not be mapped when using a transcriptomic
reference. Genomic mapping is therefore capable of discovering novel transcripts, such as new
splice variants, while transcriptomic mapping is not [53]. Novel transcripts are one contributing
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factor to the total number of unmapped reads, alongside potential contamination or fragments
that are too small or inaccurate to map. Therefore, studies targeting unmapped reads often focus
on novel gene or splice variant discovery [54][55]. Novel transcripts are therefore likely a
component of the unmapped reads found in this study (Table 5).
When using genomic mapping, quantitation of known target genes changed in ways that
disagreed with existing studies. Most notably, the extremely well characterized Notch target
HES5 was completely absent from the genomic mapped dataset (Table 2). In addition to being a
known Notch target [56], HES5 is also noted for having high expression in the SUPT1 cell line
under normal conditions [49][48]. When mapped to a reference transcriptome, however,
transcripts for HES5 are found in the sequencing dataset. suggesting that the issue with
quantitation is purely computational. Additional Notch targets, such as HEY1, are also affected
by these different mapping techniques, however, others still seem to be mostly unaffected, such
as HES1 (Table 2).
Theoretically, these differences between mapping strategies should not be present. These
differences do not appear to be associated with the total number of introns in a gene, however.
HES1, which remained similar between mapping references, has 3 introns. HES5 and HEY1,
which were both affected, have 2 and 5 respectively [57][58][59]. With the splice-aware settings
used by minimap2 when aligning to the genome, introns should not affect overall alignment [44].
This discrepancy could have many underlying explanations. Other preliminary studies have
noted small differences between minimap2 genomic alignment and transcriptome-specific
alignment tools [60]. Algorithmic differences between splice-aware and map-ont settings of
minimap2 may explain this difference, however, further experimentation in other DE contexts
with known target genes would be necessary to verify this.
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The second key way in which the ONT pipeline should be updates is in normalization.
This pipeline uses the software tool Salmon for read quantitation and normalization [29]. Salmon
normalizes based on Transcripts Per Million (TPM), a simple normalization method that only
accounts for bulk quantities of RNA reads in each sample. This creates problems when the
distribution of RNA is different between samples, which is expected in differential expression
studies. Instead of TPM, modern RNA-Seq analysis uses direct counts of mapped transcripts,
which are then normalized using downstream analysis [61]. Recently, TPM has been replaced by
various other normalization methods, including DESeq2 median-of-ratios normalization [46].
As mentioned previously, nanopore sequencing allows for single reads to provide
coverage on an entire transcript. Direct quantitation should theoretically be possible, without the
need for any form of normalization. Additionally, barcoding samples and loading them on the
same flow cell should theoretically reduce technical variation. Based on the total read counts
from each sample, this is not the case (Table 5). Notably, E5 and E6 occurred on a different flow
cell than the other three trials, and both exhibit greatly reduced total read counts in each
treatment. Normalizing just on a flow cell basis does not account for all of the variation,
however. E1-DMSO and E4-DAPT both exhibited higher read counts than the other samples on
the flow cell, including the treatment they were paired with. In a situation with high variability
such as this, per-sample normalization strategies, such as DESeq2 median of ratios, should be
performed.
E5 and E6 were the only pairs of samples sequenced in their sequencing run. Since each
sample was loaded at 40 fmol, this meant that the total loaded library during this run was 160
contrasting with the 240 fmol load during the sequencing run for E1, E3, and E4. Initially, it was
hypothesized that the low overall loading capacity on a flow cell from running less samples at
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once would mean less reads competing for pores, and therefore more data would be collected per
sample. This proved to not be the case (Figure 4). This, however, is obscured by flow cell health
and reuse. Oxford Nanopore provides reagents to allow reuse of MinION flow cells [62]. While
this kit is capable of recovering some pores inactivated during previous sequencing runs, ONT
notes that it is not intended to recover all of them. E5 and E6 were run on a flow cell that had
previously been used for sequencing and subsequently washed, while other samples were run on
a fresh flow cell, offering a potential explanation for the greatly reduced total volume of data in
these two trials.
In this differential expression study, accounting for RNA composition bias is crucial.
Notch is often described as a master regulator gene, and is therefore responsible for regulating a
wide variety of genes [36][63]. Therefore, it is expected that when the Notch pathway is
inhibited, reduced expression of Notch target genes will result in a decrease in the total mRNA
produced. Since sequencing libraries are ultimately loaded in the same molar amounts, this
discrepancy can cause abnormalities in the ratios between gene read counts. DESeq2 median of
Ratios normalization was chosen to combat this and ensure that DAPT and DMSO samples were
normalized to the same scale [46]. Since this is a function of the differential expression
experimental setup and not the sequencing platform, DESeq2 median of ratios is generally
favored over TPM for Illumina applications [30][61][64].
Median of ratios normalization through DESeq2 appeared to have a positive effect on the
ability of this pipeline to identify differentially expressed genes. 69 differentially expressed
genes were identified in the normalized set, a notable increase from the 31 found without
normalization (Table 6). Normalization, however, cannot fully account for all of the
discrepancies between samples. In some cases, Notch target genes were completely absent from
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datasets with lower overall library sizes. Trials E5 and E6 often did not contain any transcripts
that were found to be significantly up or down regulated. Notably, the E6 DMSO trial did not
exhibit any transcripts in identified Notch targets except for HES4. In this case, as well as any
other sample in which a total transcript count is 0, normalization cannot account for the variation
between samples.
The final step of statistical analysis was a Benjamini-Hochberg p-value adjustment. When
performing large numbers of statistical tests at once, such as during sequencing analysis, a
certain number of significant hits are expected to yield false positives. Post-hoc adjustments are
intended to correct for this false positive rate by making tests more stringent. To analyze the
effectiveness of this strategy in nanopore sequencing, the total number of genes retained by posthoc analysis was compared to the total number of pre-adjustment hits (Table 7). On both
platforms, post-hoc testing appears to retain a similar percentage of the total genes, suggesting
that the effectiveness of post-hoc testing is not platform specific.
Appropriate post-hoc testing remains a persistent problem in differential expression
analysis. While correcting for false positives in necessary, many tests may be too stringent for
certain DE applications. In particular, most post-hoc tests assume that an extremely small
proportion of tests performed will actually be true positives [65]. The calculation of a post-hoc
test is partially dependent on the significance “rank” of the test, which brings this assumption
into the calculation. Genes higher in the significance rank order are therefore more likely to be
retained. In the case of DE analysis performed on master regulator transcription factors,
however, this may not always be the case. In this situation, Notch is responsible for regulating a
wide variety of downstream target genes, creating a situation where the number of true positives
could potentially be very high.
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Despite these limitations, the addition of both transcriptomic mapping and normalization
to a DE computational pipeline improved results for this Notch target gene identification.

4.2 Technical Limitations of Nanopore Sequencing for DE Analysis
One of the primary advantages of nanopore sequencing is its long read length. In a
differential expression study, this means that whole transcripts are theoretically able to be
sequenced with a single read. In practice, however, we found that this was not the case (Figure
3B). Modal read length was 400-500bp, with 90% of reads being under 2kb, well under the
average length of human mRNA (Figure 3A). There are two possible sources of this variation
based on read lengths alone. Either sequencing is biased towards shorter genes, or genes are only
being represented by a small fraction of their overall length. Plotting reads as a fraction of their
corresponding gene reveals that both are the case. While there is a distinct peak representing
reads that exhibit full coverage of their corresponding genes, over half of all reads represent less
than half of a complete gene transcript. Additionally, shorter genes appear to be more likely to
have reads that fully represent the gene. This is demonstrated by the dense line of genes less than
2kb long that achieve a coverage of 1.0 in Figure 3C, as well as the negative correlation between
gene length and proportional coverage of a gene by a read. This is potentially caused by
fragmentation, but it could be a shortcoming of the platform itself. Fast5 files are generated in
real time, meaning that they do not check for a complete read before writing data [66]. Future
library preparation should utilize size distribution analysis immediately prior to sequencing to
determine which is the case.
It was also found that genes can sometimes be represented by very few reads (Table 7).
For example, BMP4 was represented by less than 10 reads in all DMSO samples except for E1.
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Additionally, it was completely absent in E6. HES1, a gene that is notably active in SUPT1
cells[48], was completely absent from the DMSO controls of E5 and E6. In addition from genes
being absent from specific samples, genes are likely absent from the dataset as a whole. In total,
nanopore sequencing identified 11265 unique transcripts in the SUPT1 cell line, whereas
Illumina identified 46556 in the closely related CUTLL cell line (Table 5). This indicates that
many genes may simply be missing from the dataset entirely, being represented by zero
transcripts in any experiment.

4.3 Identification of Notch Targets
Nanopore DE analysis identified 69 differentially expressed genes between the DMSO
and DAPT treatments. Of these, 56 were downregulated upon Notch inhibition, and can therefore
be identified as potential Notch target genes (Table 5). Among the downregulated genes are
many canonical Notch targets, such as the HES family genes HES1, HES4, and HES5. All three
of these genes are well known downstream elements of Notch signaling, with roles in cellular
development [56][57][67]. Identification of these genes as Notch targets therefore serves as an
important confirmation of the effectiveness of the technology. HEY family genes also serve
important roles in downstream Notch signaling [68]. HEY1 was the most significantly
downregulated gene upon Notch inhibition, providing another canonical Notch target to support
the validity of the platform.
DE analysis also identified less canonical Notch targets. BMP4 and CR2 have both been
shown to be transcriptionally activated by Notch in low throughput, targeted studies [69][70].
The most significantly downregulated gene after HEY1 was CPA4, a carboxypeptidase and
known oncogene [71]. While no direct link between Notch and CPA4 has been established
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through targeted techniques, other high throughput studies have identified CPA4 as a potential
Notch target through both DE analysis and examination of Notch binding sites in chromatin
[72][36].
None of the genes found to be upregulated are known Notch targets. Some, such as
DNTT, have related functions. DNTT plays a role in lymphoblast differentiation alongside Notch
target genes, but Notch signaling does not induce its transcription [73]. Upregulated genes may
be explained by continuations of other Notch-related pathways, however. The HES family of
genes, including HES1 and HES5, function as transcriptional repressors[57][67]. Consequently,
the observed downregulation in these genes due to a loss in Notch may cause transcription of
other genes, or upregulation of other signaling pathways. While no direct molecular link has
been observed, both HES1 and DNTT play a role in lymphoblast differentiation, suggesting they
may share downstream pathways [74].
The higher throughput PromethION sequencing platform may help alleviate some of
these problems. The underlying pore chemistry of a PromethION is largely shared with the
MinION; however, it offers more pores per flow cell, as well as the ability to sequence on
multiple flow cells in parallel [75][26]. The end result of this is larger total read acquisition,
increasing the overall throughput of a sequencing run. Since important details of pore chemistry,
such as translocation speed, remain similar between platforms, the PromethION is unlikely to
solve the noted issues regarding read length (Figure 3)[75][26].

4.4 Comparison to Illumina DE Analysis
The power of this platform to identify both canonical Notch targets and less well
characterized Notch targets through DE analysis demonstrates its utility, however, nanopore
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sequencing still dramatically underperforms when compared to Illumina sequencing. All 69
significantly differentially expressed genes identified using nanopore sequencing were also
identified using Illumina sequencing. Illumina sequencing also identified an additional 539 genes
that were upregulated upon Notch inhibition, and an additional 627 that were downregulated
(Table 6). This is likely due to the technical limitations of nanopore sequencing discussed
previously, ultimately affecting the total number of significant hits found. It should be noted that
Illumina data was collected in a CUTLL cell line, as opposed to the SUPT1 cells used for
nanopore sequencing. However, this difference is likely not enough to account for the
dramatically different numbers of significant genes identified, as both cell lines are T-ALL. Cell
line differences are potentially seen in two genes, however. Amyloid beat precursor protein
(APP) and Polycomb Group Ring Finger 5 (PCGF5) are significant by pre-adjustment p-value in
the Nanopore dataset, but are completely absent from the Illumina set. BH adjustment removes
this significance. Even if they are not truly significant between DAPT and DMSO trials, their
presence in SUPT1 data and not CUTLL indicates that they may be cell line specific. APP is
most notable for its role in Alzheimer’s disease as a precursor to beta-amyloid [76], but
expression has also been reported in lymph nodes and immune cells [77]. PCG5 promotes RNA
polymerase II function, and has also been reported in immune cells [78][79]. Both have some
implication in transcriptional regulation.
A likely factor in the MinION’s reduced ability to identify differentially expressed genes
is the low overall throughput of the platform when compared with Illumina, offering about 68%
of total bp read. When normalizing the number of significant genes discovered to throughput,
however, nanopore still underperforms when compared to Illumina (Table 6), weakening its
applicability to DE analysis.
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In addition to the low throughput, differences between the platform may also be
explained by the different cell lines used between the two experiments. 88.6% of all genes with
transcript counts above 0 in any experiment were also found in the Illumina experiments. As the
results discussed above have shown, the Illumina platform generally outperforms the nanopore
platform in throughput and gene discovery. As such, this difference is likely not entirely
attributable to the nanopore system discovering transcripts that the Illumina experiment failed to.
Rather, it possibly represents genes that are expressed in the SUPT1 cell line that are not present
in CUTLL cells.
Previous uses of nanopore sequencing in RNA-Seq have generally had mixed results.
In viral genomes, nanopore sequencing appears to provide better accuracy for dense, overlapping
genes [80]. In Eukaryotic yeast, RNA-Seq was found to provide lower accuracy and inconsistent
mapping when compared to Illumina. Further refinement to long-read mapping may help
alleviate this problem. Despite this, overall coverage of RNA-Seq reads appears to be similar to
Illumina due to the long length of individual reads [81]. In our study, 6.903 GB of data were
collected over five paired trials, indicating a large number of experiments to achieve Illuminalevel results (Table 5). Together with the data shown in this study, this shows a consistent trend.
In metrics where coverage and precise assembly is required, long nanopore sequencing performs
well, however, when precise quantitation is required, it falls behind existing sequencing
methodologies.
A previous study by Massui et al. demonstrated similar results to Illumina in RNA-Seq
trials [51]. In their experiments, RNA-Seq data was collected from cardiac fibroblasts and
examined for total gene discovery. These genes were then assessed for agreement to Illumina
datasets used in similar studies. Since this study is not a differential expression study and
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addresses a different biological question, the results are not quantitatively comparable to our
experiments. Despite this, the total throughput that the authors used to achieve Illumina level
results is worth noting (Table 9). Compared to our 6.9 GB of total read data collected, this study
collected 23 GB in total. They were able to achieve this many reads by spreading their trials
across five separate flow cells, each loaded to a 200 fmol capacity. This means more transcripts
were loaded to be sequenced in total. Possibly more importantly, however, is the number of flow
cells used. As noted previously, the throughput of nanopore sequencing is primarily limited by
the lifespan of the pores [21]. Using more flow cells, each containing their own set of pores, is
one method of increasing the total number of pores utilized in each experimental run.
Oxford Nanopore sequencing still has other potential applications. The consistency at
which it can identify a subset of significant genes identified by Illumina suggest utility in
preliminary research and education, where Illumina sequencing would be prohibitively
expensive. Nanopore sequencing can also be used alongside Illumina to produce accurate hybrid
assemblies, allowing for both accurate de novo sequencing and more precise quantitation
[5][82][24].
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5 CONCLUSION
Existing analysis tools and pipelines [29][44] require careful consideration and updating
when being applied to third-generation, ultralong read sequencing technologies. The pipeline
used in this study was able to effectively identify Notch target genes through differential
expression analysis. When compared to existing Illumina sequencing datasets, however, it was
found that nanopore sequencing still cannot perform at the same level as second-generation
sequencing techniques for this application, even when considering the reduced overall
throughput of the platform. All genes identified on an ONT platform were also identified on an
Illumina platform, and the Illumina platform was able to identify many additional Notch targets.
Despite being a useful tool for applications where long reads are required, nanopore sequencing
appears to consistently struggle with precise quantitation. Despite this, it may still be applied to
differential expression problems in which cost would normally be prohibitive, such as
preliminary studies, field studies, and education.
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